CN1557446A - Compound medicine for treating gout - Google Patents
Compound medicine for treating gout Download PDFInfo
- Publication number
- CN1557446A CN1557446A CNA2004100234392A CN200410023439A CN1557446A CN 1557446 A CN1557446 A CN 1557446A CN A2004100234392 A CNA2004100234392 A CN A2004100234392A CN 200410023439 A CN200410023439 A CN 200410023439A CN 1557446 A CN1557446 A CN 1557446A
- Authority
- CN
- China
- Prior art keywords
- medicine
- gout
- treatment
- radix
- compound medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 201000005569 Gout Diseases 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 239000008589 Cortex Fraxini Substances 0.000 claims description 13
- 241000237903 Hirudo Species 0.000 claims description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 4
- 241000545744 Hirudinea Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 24
- 239000000284 extract Substances 0.000 description 16
- 238000002156 mixing Methods 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 5
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 210000003423 ankle Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 210000001226 toe joint Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000019890 Amylum Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410023439 CN1241630C (en) | 2004-01-15 | 2004-01-15 | Compound medicine for treating gout |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410023439 CN1241630C (en) | 2004-01-15 | 2004-01-15 | Compound medicine for treating gout |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1557446A true CN1557446A (en) | 2004-12-29 |
CN1241630C CN1241630C (en) | 2006-02-15 |
Family
ID=34352135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410023439 Expired - Lifetime CN1241630C (en) | 2004-01-15 | 2004-01-15 | Compound medicine for treating gout |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1241630C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1326553C (en) * | 2005-11-23 | 2007-07-18 | 安徽省药物研究所 | Medicine for treating gout and preparing method |
CN102988640A (en) * | 2012-11-02 | 2013-03-27 | 樊梅 | External-use power for treating gout |
CN104510759A (en) * | 2014-03-24 | 2015-04-15 | 广西卫生职业技术学院 | Medicinal use of gilt-edged leech |
CN110433244A (en) * | 2019-09-12 | 2019-11-12 | 张伟夫 | A kind of preparation method of composition, gout tea bag and gout tea bag |
-
2004
- 2004-01-15 CN CN 200410023439 patent/CN1241630C/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1326553C (en) * | 2005-11-23 | 2007-07-18 | 安徽省药物研究所 | Medicine for treating gout and preparing method |
CN102988640A (en) * | 2012-11-02 | 2013-03-27 | 樊梅 | External-use power for treating gout |
CN102988640B (en) * | 2012-11-02 | 2014-06-04 | 樊梅 | External-use power for treating gout |
CN104510759A (en) * | 2014-03-24 | 2015-04-15 | 广西卫生职业技术学院 | Medicinal use of gilt-edged leech |
CN110433244A (en) * | 2019-09-12 | 2019-11-12 | 张伟夫 | A kind of preparation method of composition, gout tea bag and gout tea bag |
Also Published As
Publication number | Publication date |
---|---|
CN1241630C (en) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1768812A (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
CN1895642A (en) | Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain and preparation method thereof | |
CN1861163A (en) | Traditional Chinese medicine composition for treating kidney-yang deficiency and deficiency of vital energy and blood, its prepn. process | |
CN100342889C (en) | Chinese medicine for treating gout | |
CN1726929A (en) | Compsn. of medication for treating diabetes | |
CN1256969C (en) | Chinese medicine for treating bone disease and its preparation | |
CN1241630C (en) | Compound medicine for treating gout | |
CN1840160A (en) | Powder for resisting hyperosteogeny | |
CN1973878A (en) | Medicine for treating children's stomachache and its prepn | |
CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
CN1197614C (en) | Chinese medicine cap sule for treating prostatic disorders | |
CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
CN1254267C (en) | Medicine for treating gastral cavity pain and its preparation method | |
CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
CN1215595A (en) | External use medicine for treating soft tissue injury and its producing method | |
CN1840101A (en) | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof | |
CN1203876C (en) | Medicine for curing postpartum subinvolution of uterus and its preparation method | |
CN1471954A (en) | Chinese medicine for withdrawal of drug dependence | |
CN1030373C (en) | Medicine for waist rheumatism | |
CN1883697A (en) | Pharmaceutical composition for treating sterility and preparation method thereof | |
CN1261156C (en) | Medicine for treating chronic gastroenteritis and colitis | |
CN1850265A (en) | Chinese medicine for treating nephrosis Yang deficiency syndrome | |
CN1650959A (en) | Wine for dispelling wind and removing obstruction in channels and its preparation method | |
CN1216634C (en) | Medicinal composition for treating pain | |
CN1212132C (en) | Chinese medicine for treating rheumatic diseases and its prepn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU JINGXIUTANG( PHARMACEUTICAL ) CO., LTD. Free format text: FORMER OWNER: GUANGZHOU JINGXIUTANG( PHARMACEUTICAL ) CO., LTD.; SHANDONG CHINESE MEDICINE UNIV. Effective date: 20070427 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070427 Address after: 510130 No. 179 Renmin South Road, Guangdong, Guangzhou Patentee after: Guangzhou JingXiuTang Pharmaceutical Co.,Ltd. Address before: 510130 No. 179 Renmin South Road, Guangdong, Guangzhou Co-patentee before: Shandong University of Traditional Chinese Medicine Patentee before: Guangzhou JingXiuTang Pharmaceutical Co.,Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: GUANGZHOU BAIYUNSHAN JINGXIUTANG PHARMACEUTICAL CO Free format text: FORMER NAME: JINGXIUTANG (PHARMACEUTICAL) CO., LTD., GUANGZHOU;JINGXIUTANG (PHARMACEUTICAL) CO., LTD., GUANGZHOU |
|
CP03 | Change of name, title or address |
Address after: 510130 No. 179 Renmin South Road, Guangzhou, Guangdong, Liwan District Patentee after: GUANGZHOU BAIYUNSHAN JINGXIUTANG PHARMACEUTICAL Co.,Ltd. Address before: 510130 No. 179 Renmin South Road, Guangdong, Guangzhou Patentee before: Guangzhou JingXiuTang Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20060215 |
|
CX01 | Expiry of patent term |